Lao factory producing Molacovir for treatment of Covid-19 patients


VIENTIANE, Jan 4 (vientiane Times/ANN): State Enterprise Pharmaceutical Factory No. 3 in Vientiane is manufacturing a revolutionary new drug named Molacovir for use in the early stages of Covid-19.

The drug is administered orally and under Lao copyright is known as Molacovir.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Laos , Molacovir , Own Production , Covid-19 , Patients

Next In Aseanplus News

Asian Games: Taiwan's Lin wins Asiad gold two years after Olympics gender row; India's Lovlina Borgohain also bags gold after defeating Chinese
Asian Games - Chinese judoka DQ'd after alleged biting incident
Police report lodged against motivational speaker over alleged child sexual harassment
With a mixed scorecard, Trump poised to test his powers again at US Supreme Court
Taiwan plans US$850 million ammunition spend to prepare for potential PLA blockade
Pakistan says Mecca pact members to hold emergency talks on engaging Houthis
New islands appear after Indonesia's Anak Krakatau volcano erupts
Asean News Headlines at 10pm on Friday (Oct 2, 2026)
Myanmar ships with returnees from Malaysia enter home waters, state media says
Asean talks on strengthening regional information and media cooperation

Others Also Read